On June 14, 2021, Kiwoom Securities is a veterinary pharmaceutical company based on DNA gene therapy technology
for "Plumline Life Science," a bio company focusing on veterinary medicine, and manufactures therapeutics for companion animals and
livestock based on the DNA treatment platform and sales.

https://www.news2day.co.kr/article/20210614500198